Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
75 Cards in this Set
- Front
- Back
Diffuses into extravascular spaces
|
IgG
|
|
Can cross placenta
|
IgG
|
|
Can activate complement
|
IgG
|
|
Pentamer - large size
|
IgM
|
|
Limited to intravascular areas
|
IgM
|
|
Acute disease
|
IgM
|
|
In secretions
|
IgA
|
|
Surface of B lymphs in association with IgM
|
IgD
|
|
Elevated in hypersensitivity reactions, allergies, parasitic infections
|
IgE
|
|
Basophils - histamine & heparin
|
IgE
|
|
IgE-mediated
|
Type 1
|
|
RAST
|
Type 1
|
|
Cytotoxic/cell-mediated
|
Type 2
|
|
Free Ab reaction with Ag associated with cell surfaces
|
Type 2
|
|
ABO transfusion reactions
|
Type 2
|
|
Immune complexes
|
Type 3
|
|
Decrease in C3, C4, C50
|
Type 3
|
|
Delayed hypersensitivity (24-48 hours after exposure)
|
Type 4
|
|
Contact dermatitis
|
Type 4
|
|
PPD screening
|
Type 4
|
|
Looking for antigen
|
DFA - chlamydia testing, legionella
|
|
Looking for antibody
|
IFA - ANA, FTA-ABS
|
|
Measure concentration, sensitive, detects trace amounts (T3, T3, TSH, B-HCG)
|
RIA
|
|
Latex coated with antigen to look for antibody
|
Latex aggultination
|
|
Latex agglutination
|
Monospot, strep screen
|
|
Clumping of particles to form visible masses
|
Flocculation
|
|
Flocculation
|
RPR
|
|
ANA
|
Collagen, rheumatic, connective tissue disease, mainly to screen for SLE
|
|
Anti-tissue necrosis
|
Crohn's disease
|
|
Anti-gliadin
|
Celiac's disease
|
|
Anti-endomysial
|
Celiac's disease
|
|
Anti-tissue transglutaminase
|
Celiac's disease
|
|
Deaminated gliadin peptide
|
Celiac's disease
|
|
Homogenous ANA
|
SLE
|
|
Nuclear rim ANA
|
SLE
|
|
Speckled ANA
|
SLE, Sjogren's, RA, polymyositis, mixed ct disease
|
|
Nucleolar ANA
|
Scleroderma, polymyositis, vasculitis
|
|
Anti-dsDNA
|
SLE (exacerbation, active state, dec'd with therapy)
|
|
Anti-Sm
|
SLE (does not correlate well with disease activity)
|
|
Anti-cardiolipin
|
SLE
|
|
Anti-SSA (Ro)
|
SLE & Sjogren's
|
|
Anti-SSB (La)
|
SLE & Sjogren's
|
|
Antihistone
|
Drug-induced lupus
|
|
Anti-Scl70
|
Scleroderma
|
|
RF
|
RA (but not specific), severity of disease & presence of nodules
|
|
Anti-CCP
|
RA (much sooner & more accurate - more likely to develop erosive type)
|
|
ANCA
|
Wegner's granulomatosus
|
|
C3
|
Most abundant, 1st measured
|
|
C4
|
More sensitive & specific
|
|
CH50
|
Total complement
|
|
Acute phase reactants
|
CRP, fibrinogen, ferritin, complement
|
|
hs-CRP
|
CV disease
|
|
Anti-thyroglobulin
|
thyroid
|
|
Anti-peroxidase
|
thyroid
|
|
Anti-microsomal
|
thyroid
|
|
ASMA
|
Liver & bile duct AI disease, hepatitis, biliary cirrhosis, asthma
|
|
APCA
|
Pernicious anemia & chronic gastric disease
|
|
ASO
|
Dx of prior not acute infxn, inc'd in RF, glomerulonephritis, pyoderma
|
|
RPR
|
2 and latent stages of syphilis, non-Treponemal, screening test
|
|
FTA-ABS
|
Confirms dx of syphilis, Treponemal
|
|
VDRL
|
Tertiary syphilis (neurosyphilis)
|
|
Lyme
|
Elisa (screen), Western Blot (confirm)
|
|
Calcitonin
|
Thyroid medullary carcinoma, oat cell, breast, pancreatic
|
|
CEA
|
Colorectal cancer but not reliable or specific
|
|
AFP
|
Testicular CA, hepatic CA, hepatomas, neural tube defects, ovarian cancer
|
|
B-HCG
|
Pregnancy, trophoblastic tumors, hydatidform moles, breast & testicular CA
|
|
PSA
|
BPH & prostate CA
|
|
CA-125
|
Ovarian CA
|
|
CA 15-3, CA 27.29
|
Breast cancer staging and monitoring tx
|
|
CA19-9
|
Pancreatic & hepatobiliary, stomach CA
|
|
EBV
|
Burkitt's lymphoma, nasopharyngeal CA
|
|
HBV
|
Hepatocellular CA
|
|
HHV8
|
Kaposi's sacroma
|
|
HPV
|
Cervical carcinoma
|
|
HTLV1
|
Adult T-cell leukemia
|